Truist Financial Corp Increases Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Truist Financial Corp raised its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.4% during the fourth quarter, Holdings Channel.com reports. The fund owned 48,880 shares of the company’s stock after purchasing an additional 1,154 shares during the quarter. Truist Financial Corp’s holdings in Acadia Healthcare were worth $3,801,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Headlands Technologies LLC bought a new stake in Acadia Healthcare in the third quarter valued at $25,000. GAMMA Investing LLC bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at about $26,000. Fifth Third Bancorp increased its position in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares during the period. DekaBank Deutsche Girozentrale bought a new position in Acadia Healthcare in the third quarter worth about $96,000. Finally, Oak Thistle LLC purchased a new stake in Acadia Healthcare in the fourth quarter worth about $235,000.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, March 5th. TD Cowen increased their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. Barclays reduced their target price on shares of Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating on the stock in a research report on Thursday, May 2nd. Finally, TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.89.

Insider Activity at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is currently owned by insiders.

Acadia Healthcare Stock Up 2.5 %

Shares of Acadia Healthcare stock opened at $67.78 on Tuesday. The company has a 50-day simple moving average of $76.42 and a two-hundred day simple moving average of $77.45. Acadia Healthcare Company, Inc. has a 52-week low of $64.74 and a 52-week high of $87.77. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. The stock has a market capitalization of $6.29 billion, a PE ratio of -484.11, a price-to-earnings-growth ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.75 EPS. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.56 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.